Zealand Pharma A/S (ZLDPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 602,753 | 692,888 | 935,327 | 1,101,820 | 109,515 |
| Marketable Securities | 1,662,935 | 1,594,585 | 1,596,807 | 1,419,676 | 1,096,109 |
| Receivables | 37,427 | 48,400 | 70,724 | 64,905 | 56,852 |
| Inventories | N/A | N/A | N/A | 1,566 | 1,510 |
| Other current assets | 1 | 0 | 0 | 0 | 1 |
| TOTAL | $2,351,819 | $2,372,455 | $2,602,857 | $2,587,967 | $1,263,986 |
| Non-Current Assets | |||||
| PPE Net | 12,058 | 10,583 | 8,731 | 8,300 | 7,131 |
| Intangibles | 7,047 | 6,808 | 1,994 | 2,067 | 1,995 |
| Other Non-Current Assets | 25,213 | 24,802 | 16,867 | 14,754 | 14,035 |
| TOTAL | $44,318 | $42,193 | $27,592 | $25,121 | $23,161 |
| Total Assets | $2,396,137 | $2,414,648 | $2,630,449 | $2,613,088 | $1,287,146 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 53,557 | 87,357 | 72,258 | 63,899 | 48,031 |
| TOTAL | $63,266 | $100,676 | $184,564 | $171,482 | $50,352 |
| Non-Current Liabilities | |||||
| Long Term Debt | 48,076 | 45,863 | 46,737 | 44,717 | 40,888 |
| Deferred Revenues | 5,168 | 9,893 | 18,970 | 23,406 | N/A |
| Other Non-Current Liabilities | 18,949 | 22,755 | 24,174 | 20,873 | 23,580 |
| TOTAL | $67,025 | $68,618 | $71,421 | $67,508 | $64,468 |
| Total Liabilities | $130,291 | $169,293 | $255,985 | $238,990 | $114,819 |
| Shareholders' Equity | |||||
| Common Shares | 11,275 | 10,827 | 11,176 | 10,851 | 10,025 |
| Retained earnings | -55,750 | 952 | 55,599 | 122,171 | -912,906 |
| Other shareholders' equity | 3,601 | 3,540 | 3,638 | 3,520 | 3,254 |
| TOTAL | $2,265,845 | $2,245,355 | $2,374,463 | $2,374,098 | $1,172,327 |
| Total Liabilities And Equity | $2,396,136 | $2,414,648 | $2,630,448 | $2,613,088 | $1,287,146 |